EUVIMEDEUVIMED entdecken
Open Access

Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model

Yu Liao iD, Xun Yuan, An-Qi Qin, Yi-Cheng Qi iD, Chang Shan, Jing Ma iD

Diabetes, Obesity and Metabolism · 2026-09 · 28 (9) · 7834-7848

DOI: 10.1111/dom.70972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 09.06.2026. Verfasst von Yu Liao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Bifidobacterium breve, Obesity, Dysbiosis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation Promotion Project within Renji Hospital, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to evaluate the modulatory effects of Bifidobacterium breve BBr60 on gut microbiota dysbiosis and metabolic abnormalities in a high‐fat diet (HFD) ‐induced obese mouse model.

Methods

Thirty mice aged 6 weeks were divided into a normal diet group (CTL), an HFD group, and a BBr60 intervention group (HFD + BBr60). During 8 weeks, the food intake and body weight of the mice were monitored. Subsequently, an oral glucose tolerance test (OGTT) was conducted, and fasting insulin levels, lipid profiles, and the gut microbiota composition were determined. Liver lesions, inflammation levels, and tight junction protein expression were examined using Oil Red O staining, haematoxylin and eosin staining, and reverse transcription polymerase chain reaction analysis, respectively. 16s rRNA high‐throughput sequencing techniques were used to investigate the diversity and richness of the gut microbiota.

Results

BBr60 not only ameliorated HFD‐induced metabolic disorders, including weight gain (body weight, p < 0.001), hyperglycaemia (FBG, p < 0.001), insulin resistance (HOMA‐IR, p = 0.002), dyslipidaemia (TC, p < 0.001), and liver steatosis, but also mitigated systemic inflammation and impaired intestinal permeability. Furthermore, BBr60 reversed gut microbiota dysbiosis, as evidenced by a significant reduction in the relative abundance of opportunistic pathogens such as Duncaniella, Allobaculum , and Parasutterella while increasing beneficial bacteria such as Clostridium cluster XIVa, Limosilactobacillus , and Bifidobacterium . Time‐dynamic analyses showed that BBr60 regulated the relative abundance of the gut microbiota and improved HFD‐induced dysbiosis of the gut microbiota.

Conclusion

BBr60 significantly ameliorated glucose and lipid metabolic disorders and gut microbiota dysbiosis in an HFD‐induced obese mouse model, and these effects were associated with changes in gut microbiota composition, suggesting its potential as a therapeutic intervention for obesity‐related metabolic abnormalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBifidobacterium breveObesityDysbiosisProbioticsAnimalsDiet, High-FatMiceMaleDisease Models, AnimalMice, Inbred C57BLMice, ObeseInsulin Resistance

Stichwörter der Autor:innen

Bifidobacterium brevegut microbiotametabolic abnormalitiesobesity

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • School of Life Sciences and Technology, Tongji University, Shanghai, China.

ORCID-Profile: Yu Liao, Yi-Cheng Qi, Jing Ma

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation Promotion Project within Renji Hospital, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Liao, Y., Yuan, X., Qin, A. Q., Qi, Y. C., Shan, C., & Ma, J. (2026). Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model. Diabetes, Obesity and Metabolism, 28(9), 7834-7848. https://doi.org/10.1111/dom.70972

Vancouver

Liao Y, Yuan X, Qin AQ, Qi YC, Shan C, Ma J. Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model. Diabetes, Obesity and Metabolism. 2026;28(9):7834-7848. doi:10.1111/dom.70972

BibTeX
@article{Liao2026,
  author = {Liao, Yu and Yuan, Xun and Qin, An-Qi and Qi, Yi-Cheng and Shan, Chang and Ma, Jing},
  title = {Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High‐Fat Diet‐Induced Obese Mouse Model},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {9},
  pages = {7834--7848},
  doi = {10.1111/dom.70972}
}
Kostenlos starten →